Free Trial

GSK (GSK) News Today

GBX 1,529.50
+1.00 (+0.07%)
(As of 09:57 AM ET)
GSK logo with Medical background
GSK (LON:GSK) PT Lowered to GBX 1,900
Citigroup lowered their price target on shares of GSK from GBX 2,120 ($26.82) to GBX 1,900 ($24.03) and set a "buy" rating on the stock in a research report on Friday.
GSK logo with Medical background
GSK (LON:GSK) Given "Underweight" Rating at JPMorgan Chase & Co.
JPMorgan Chase & Co. reiterated an "underweight" rating on shares of GSK in a research note on Tuesday.
GSK logo with Medical background
GSK (LON:GSK) Stock Rating Reaffirmed by Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 1,950 ($24.74) target price on shares of GSK in a research note on Friday.
GSK logo with Medical background
GSK plc (LON:GSK) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of GSK plc (LON:GSK - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a bu
GSK logo with Medical background
GSK (LON:GSK) Stock Rating Reaffirmed by Shore Capital
Shore Capital restated a "buy" rating on shares of GSK in a research note on Thursday.
GSK logo with Medical background
Wendy Becker Acquires 446 Shares of GSK plc (LON:GSK) Stock
GSK plc (LON:GSK - Get Free Report) insider Wendy Becker acquired 446 shares of the stock in a transaction that occurred on Thursday, June 20th. The shares were bought at an average price of GBX 1,614 ($20.51) per share, for a total transaction of £7,198.44 ($9,146.68).
GSK logo with Medical background
JPMorgan Chase & Co. Reaffirms "Underweight" Rating for GSK (LON:GSK)
JPMorgan Chase & Co. reissued an "underweight" rating on shares of GSK in a research note on Tuesday.
Julie Brown Purchases 8 Shares of GSK plc (LON:GSK) Stock
GSK plc (LON:GSK - Get Free Report) insider Julie Brown acquired 8 shares of the company's stock in a transaction that occurred on Tuesday, June 11th. The shares were acquired at an average cost of GBX 1,623 ($20.67) per share, for a total transaction of £129.84 ($165.34).
GSK (LON:GSK) Receives Underweight Rating from JPMorgan Chase & Co.
JPMorgan Chase & Co. reiterated an "underweight" rating on shares of GSK in a research note on Tuesday.
GSK to sell entire Haleon stake
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK (LON:GSK) Reaches New 12-Month High at $1,767.50
GSK (LON:GSK) Sets New 12-Month High at $1,767.50
GSK's (GSK) Equal Weight Rating Reiterated at Barclays
Barclays reiterated an "equal weight" rating and issued a GBX 1,725 ($21.67) price objective on shares of GSK in a research report on Tuesday.
GSK (LON:GSK) Price Target Increased to GBX 1,660 by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted their price objective on shares of GSK from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) and gave the stock an "underweight" rating in a research note on Thursday.
GSK (LON:GSK) Sets New 1-Year High After Dividend Announcement
GSK (LON:GSK) Sets New 12-Month High After Dividend Announcement
GSK plc (LON:GSK) to Issue GBX 15 Dividend
GSK plc (LON:GSK) declared a dividend on Wednesday, May 1st. Investors of record on Thursday, May 16th will be paid a dividend of GBX 15 ($0.19) per share on Thursday, July 11th. This represents a yield of 0.9%. The ex-dividend date of this dividend is Thursday, May 16th. The official announcement can be seen at this link.
GSK (LON:GSK) Earns Buy Rating from Shore Capital
Shore Capital reiterated a "buy" rating on shares of GSK in a report on Wednesday.
Deutsche Bank Aktiengesellschaft Reaffirms "Buy" Rating for GSK (LON:GSK)
Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a GBX 1,950 ($24.27) target price on shares of GSK in a research note on Wednesday.
GSK May 2024 28.000 call (GSK240517C00028000)
Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

Home To The World’s Largest High-Grade Uranium Deposits (Ad)

Nuclear is one of the safest forms of energy around. In its entire history, nuclear is responsible for fewer deaths than oil and gas pollution cause every year. And investors are eyeing uranium exploration companies as one of the surest plays on the current nuclear renaissance.

Click here to see why this could be one of the greatest periods for the nuclear industry ever

GSK Media Mentions By Week

GSK Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GSK
News Sentiment

0.00

0.93

Average
Medical
News Sentiment

GSK News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GSK Articles
This Week

0

6

GSK Articles
Average Week

Get GSK News Delivered to You Automatically

Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (LON:GSK) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners